A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. - Lebwohl,M.; Tyring,S.K.; Hamilton,T.K.; Toth,D.; Glazer,S.; Tawfik,N.H.; Walicke,P.; Dummer,W.; Wang,X.; Garovoy,M.R.; Pariser,D. (New Engl J Med, 2003)